Golden State Wealth Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11
Closed -$1.12K 1656
2025
Q4
$1.12K Buy
+11
New +$883 ﹤0.01% 1495
2025
Q2
Sell
-200
Closed -$8.66K 1593
2025
Q1
$8.66K Buy
+200
New +$10.1K ﹤0.01% 1033
2020
Q2
Sell
-310
Closed -$18K 409
2020
Q1
$18K Buy
+310
New +$25.2K 0.01% 519
2019
Q4
Sell
-510
Closed -$46K 324
2019
Q3
$46K Hold
510
0.02% 448
2019
Q2
$60K Hold
510
0.02% 412
2019
Q1
$44K Buy
+510
New +$43.4K 0.01% 475

Other funds holding EXAS

Golden State Wealth Management's EXAS Position: Q1 2026 in Review

Golden State Wealth Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11 shares — an estimated $1.12K sold.

Golden State Wealth Management first reported a position in EXAS in Q1 2019 and held it in 6 quarters. The position peaked at $60K in Q2 2019. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Golden State Wealth Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Golden State Wealth Management sold 11 Exact Sciences shares in Q1 2026, an estimated $1.12K.
  • Golden State Wealth Management first reported a position in Exact Sciences in Q1 2019 and held it in 6 quarters.
  • Golden State Wealth Management's Exact Sciences position peaked at $60K in Q2 2019.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Golden State Wealth Management's 13F filing for Q1 2026, filed 28 Apr 2026.